Study limitation reported by the research below: “Specific systemic therapy regimens used (e.g., chemotherapy alone vs. chemotherapy plus immunotherapy) are referenced in background but not stratified in the reported outcomes, which may confound survival comparisons across the study period (2013–2023).”
